<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is a leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>deaths</z:hpo> worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Early diagnosis and treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is the key to improving survival rates and as such a need exists to identify patients who may benefit from adjuvant chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>The dysregulation of the ubiquitin-proteasome system (UPS) has been implicated in <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell survival, and <z:chebi fb="0" ids="52726">proteasome inhibitors</z:chebi> are in clinical use for a number of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> including <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In our study, we examined the protein expression of several key components of the UPS in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> using immunohistochemistry to determine expression levels of ubiquitinylated proteins and the proteasomal subunits, 20S core and Rpt4 in a cohort of 228 patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Multivariate Cox analysis revealed that neither the intensity of either ubiquitinylated proteins or the 20S core was predictive in either Stage II or III <z:hpo ids='HP_0003003'>colon cancer</z:hpo> for disease free survival or overall survival </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, in Stage II patients increased Rpt4 staining was significantly associated with disease free survival (Cox proportional hazard ratio 0.605; p = 0.0217) </plain></SENT>
<SENT sid="6" pm="."><plain>Our data suggest that Rpt4 is an independent prognostic variable for <z:e sem="disease" ids="C0677948" disease_type="Neoplastic Process" abbrv="">Stage II colorectal cancer</z:e> and may aid in the decision of which patients undergo adjuvant chemotherapy </plain></SENT>
</text></document>